Skip to main content
. 2021 Mar 19;13(3):999. doi: 10.3390/nu13030999

Table 4.

Evaluation of symptoms relief.

Treatment n (%) Within the First Week of Intake Within 2 Weeks of Intake After More than 2 Weeks of Intake No Improvement
µsmin® Plus 37 (100) 4 (10.81) 25 (67.57) 7 (18.92) 1 (2.70)
Placebo 35 (100) 0 4 (11.43) 6 (17.14) 25 (71.43)